Join the Amyotrophic Lateral Sclerosis group to help and get support from people like you.
Amyotrophic Lateral Sclerosis News
Related terms: ALS (amyotrophic lateral sclerosis), Amyotrophic Lateral Sclerosis (ALS), Lou Gehrig's Disease, Motor Neurone Disease, ALS
Mortality From ALS Up With Exposure to Cyanobacterial Harmful Algal Blooms
THURSDAY, June 26, 2025 – Living close to cyanobacterial harmful algal blooms in U.S. water bodies is associated with increased risk of mortality from amyotrophic lateral sclerosis (ALS), according...
Trend Toward Survival Benefit Seen for REM-Inhibition in ALS
THURSDAY, May 22, 2025 – For patients with amyotrophic lateral sclerosis (ALS), rapid eye movement (REM) inhibition via receipt of antidepressant medication is associated with a trend toward...
What You Should Know About ALS, Also Known as Lou Gehrig’s Disease
SATURDAY, May 3, 2025 — Amyotrophic lateral sclerosis (ALS) – known as Lou Gehrig’s Disease based on the iconic 1930s New York Yankee baseball player – is a progressive neurodegenerative disease that ...
Four Immunoassays for Neurofilament Light Chain Show Consistent Performance in ALS
THURSDAY, Feb. 27, 2025 – Four immunoassays for neurofilament light chain (NfL) demonstrate consistent performance in patients with amyotrophic lateral sclerosis (ALS), with high diagnostic and...
Blood Test Can Help Diagnose, Track ALS
THURSDAY, Feb. 27, 2025 – A blood test can help doctors detect ALS, or amyotrophic lateral sclerosis, and predict how the degenerative disease will progress in patients, a new study suggests. People...
Genetics Suggest Link Between ALS, Parkinson's Disease
MONDAY, Sept. 16, 2024 – People with rare genetic variants linked to degenerative brain disorders like Parkinson’s disease are at increased risk of developing ALS, a new study finds. Further, having ...
High Health Care Utilization, Poor Survival Seen for Over 70s With AML
MONDAY, Aug. 19, 2024 – Older patients with acute myeloid leukemia (AML) have high health care utilization and poor survival outcomes, according to a study published online Aug. 13 in Hematological...
Brain-Computer Combo Lets Mute Man With ALS 'Talk' Again
THURSDAY, Aug. 15, 2024 – Casey Harrell was losing his ability to speak due to amyotrophic lateral sclerosis (ALS), also known as Lou Gehrig’s disease. “Not being able to communicate is so fru...
Elevated Metals in Plasma, Urine Linked to ALS Risk, Survival
FRIDAY, Aug. 9, 2024 – Elevated metal levels in plasma and urine are associated with amyotrophic lateral sclerosis (ALS) risk and survival, according to a study published online Aug. 6 in the...
FDA Grants Accelerated Approval for Qalsody (tofersen) for the Treatment of Amyotrophic Lateral Sclerosis Associated with a Mutation in the SOD1 Gene
CAMBRIDGE, Mass., April 25, 2023 (GLOBE NEWSWIRE) – Biogen Inc. (Nasdaq: BIIB) announced today that the U.S. Food and Drug Administration (FDA) has approved Qalsody (tofersen) 100 mg/15mL injection...
FDA Approves Relyvrio (sodium phenylbutyrate/taurursodiol) for Patients with Amyotrophic Lateral Sclerosis (ALS)
Relyvrio (previously known as AMX0035 in the U.S.) is an oral, fixed-dose combination therapy for the treatment of adults with ALS Relyvrio significantly slowed loss of physical function in a...
FDA Approves Radicava ORS (edaravone) for the Treatment of Amyotrophic Lateral Sclerosis (ALS)
JERSEY CITY, N.J., May 13, 2022 /PRNewswire/ – Mitsubishi Tanabe Pharma Corporation (MTPA) today announced the U.S. Food and Drug Administration (FDA) has approved Radicava ORS (edaravone), the o...
FDA Approves Exservan (riluzole) Oral Film for the Treatment of Amyotrophic Lateral Sclerosis
WARREN, N.J., Nov. 25, 2019 (GLOBE NEWSWIRE) – Aquestive Therapeutics, Inc. (NASDAQ: AQST), a specialty pharmaceutical company focused on developing and commercializing differentiated products to...
ITF Pharma Announces FDA Approval of Tiglutik (riluzole) Oral Suspension for the Treatment of Amyotrophic Lateral Sclerosis (ALS)
BERWYN, Pa., Sept. 6, 2018 /PRNewswire/ – ITF Pharma, a U.S.-based specialty pharmaceutical company and a subsidiary of Italfarmaco, a privately-held European specialty pharmaceutical company,...
FDA Approves Radicava (edaravone) to Treat Amyotrophic Lateral Sclerosis (ALS)
May 5, 2017 – The U.S. Food and Drug Administration today approved Radicava (edaravone) to treat patients with amyotrophic lateral sclerosis (ALS), commonly referred to as Lou Gehrig’s disease. “...